Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jieduzhuyu Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for its antitumor, anti-inflammatory, and detoxifying properties. It is composed of multiple medicinal herbs, each contributing to the overall therapeutic effect. The decoction has been studied for its ability to inhibit tumor cell proliferation, induce apoptosis, suppress migration and invasion of cancer cells, and reduce angiogenesis. Mechanistically, it acts by inhibiting the mTOR/HIF-1α/VEGF signaling pathway in cancer models[1]. While specific ingredient lists may vary by source or clinical context, similar TCM formulas often include herbs such as Astragalus (Huang Qi), Atractylodes (Bai Zhu), Ginseng (Ren Shen), Licorice (Gan Cao), Forsythia (Lian Qiao), and Honeysuckle (Jin Yin Hua)[2]. The decoction is not a single chemical entity but a multi-herb combination designed according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jieduzhuyu Decoction.